| Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: a randomised placebo-controlled trial S Paramsothy, MA Kamm, NO Kaakoush, AJ Walsh, J van den Bogaerde, ... The Lancet 389 (10075), 1218-1228, 2017 | 1173 | 2017 |
| Faecal microbiota transplantation for inflammatory bowel disease: a systematic review and meta-analysis S Paramsothy, R Paramsothy, DT Rubin, MA Kamm, NO Kaakoush, ... Journal of Crohn's and Colitis 11 (10), 1180-1199, 2017 | 451 | 2017 |
| Specific bacteria and metabolites associated with response to fecal microbiota transplantation in patients with ulcerative colitis S Paramsothy, S Nielsen, MA Kamm, NP Deshpande, JJ Faith, ... Gastroenterology 156 (5), 1440-1454. e2, 2019 | 378 | 2019 |
| Fecal microbiota transplantation: indications, methods, evidence, and future directions TJ Borody, S Paramsothy, G Agrawal Current gastroenterology reports 15, 1-7, 2013 | 341 | 2013 |
| Fecal microbiota transplantation: indications, methods, evidence, and future directions TJ Borody, S Paramsothy, G Agrawal Current gastroenterology reports 15, 1-7, 2013 | 341 | 2013 |
| Therapeutic faecal microbiota transplantation: current status and future developments TJ Borody, LJ Brandt, S Paramsothy Current opinion in gastroenterology 30 (1), 97-105, 2014 | 195 | 2014 |
| Donor recruitment for fecal microbiota transplantation S Paramsothy, TJ Borody, E Lin, S Finlayson, AJ Walsh, D Samuel, ... Inflammatory bowel diseases 21 (7), 1600-1606, 2015 | 165 | 2015 |
| Lyophilised oral faecal microbiota transplantation for ulcerative colitis (LOTUS): a randomised, double-blind, placebo-controlled trial C Haifer, S Paramsothy, NO Kaakoush, A Saikal, S Ghaly, T Yang, ... The lancet Gastroenterology & hepatology 7 (2), 141-151, 2022 | 130 | 2022 |
| Fungal trans-kingdom dynamics linked to responsiveness to fecal microbiota transplantation (FMT) therapy in ulcerative colitis I Leonardi, S Paramsothy, I Doron, A Semon, NO Kaakoush, JC Clemente, ... Cell host & microbe 27 (5), 823-829. e3, 2020 | 127 | 2020 |
| The current state of the art for biological therapies and new small molecules in inflammatory bowel disease S Paramsothy, AK Rosenstein, S Mehandru, JF Colombel Mucosal immunology 11 (6), 1558-1570, 2018 | 112 | 2018 |
| Defined microbiota transplant restores Th17/RORγt+ regulatory T cell balance in mice colonized with inflammatory bowel disease microbiotas GJ Britton, EJ Contijoch, MP Spindler, V Aggarwala, B Dogan, G Bongers, ... Proceedings of the National Academy of Sciences 117 (35), 21536-21545, 2020 | 75 | 2020 |
| acute severe ulcerative colitis–evidence‐based consensus statements JH Chen, JM Andrews, V Kariyawasam, N Moran, P Gounder, G Collins, ... Alimentary pharmacology & therapeutics 44 (2), 127-144, 2016 | 73 | 2016 |
| Australian consensus statements for the regulation, production and use of faecal microbiota transplantation in clinical practice C Haifer, CR Kelly, S Paramsothy, D Andresen, LE Papanicolas, ... Gut 69 (5), 801-810, 2020 | 70 | 2020 |
| Epidemiology of inflammatory bowel disease in South America: A systematic review S Selvaratnam, S Gullino, L Shim, E Lee, A Lee, S Paramsothy, ... World Journal of Gastroenterology 25 (47), 6866, 2019 | 58 | 2019 |
| Superior treatment persistence with ustekinumab in Crohn’s disease and vedolizumab in ulcerative colitis compared with anti‐TNF biological agents: real‐world registry data from … Y Ko, S Paramsothy, Y Yau, RW Leong Alimentary Pharmacology & Therapeutics 54 (3), 292-301, 2021 | 46 | 2021 |
| Gastroenterologist perceptions of faecal microbiota transplantation S Paramsothy, AJ Walsh, T Borody, D Samuel, J Van Den Bogaerde, ... World Journal of Gastroenterology: WJG 21 (38), 10907, 2015 | 42 | 2015 |
| Use of medications during pregnancy and breastfeeding for Crohn’s disease and ulcerative colitis R Laube, S Paramsothy, RW Leong Expert Opinion on Drug Safety 20 (3), 275-292, 2021 | 38 | 2021 |
| An update on fecal microbiota transplantation for the treatment of gastrointestinal diseases KMJ Waller, RW Leong, S Paramsothy Journal of gastroenterology and hepatology 37 (2), 246-255, 2022 | 34 | 2022 |
| Safety of drugs used for the treatment of Crohn’s disease A Pudipeddi, V Kariyawasam, C Haifer, B Baraty, S Paramsothy, ... Expert Opinion on Drug Safety 18 (5), 357-367, 2019 | 33 | 2019 |
| Multi donor intense faecal microbiota transplantation is an effective treatment for resistant ulcerative colitis: A randomised placebocontrolled trial and microbiota analysis N Kaakoush, J Van Den Bogaerde, S Paramsothy, R Paramsothy, W Ng, ... Journal of Gastroenterology and Hepatology (Australia), 2016 | 32 | 2016 |
